Winston Kung

Winston Kung

Former Chief Operating Officer and Chief Financial OfficeratPMV Pharmaceuticals· In proxies 2022–2023

Pay in FY2023-29% from the year before · PMV Pharmaceuticals stock -64.4% the same year

Winston Kung was paid $1.3M in FY2023 (Dec), down 29%. PMV Pharmaceuticals stock fell 64.4% that year.

Pay$100 in the stock at the end of FY21 → $13
Pay is from the Summary Compensation Table of each PMV Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. PMV PharmaceuticalsPublic company · 4 yr
    • Former Chief Operating Officer and Chief Financial Officer2022 – Present · 4 yrStock in role -94%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?